Legal Help and Information for Injury Victims
Home >> Gadolinium Contrast Dye Resources >> BYETTA PATIENTS REPORT KIDNEY PROBLEMS, LABEL REVISED
Gadolinium Contrast Dye News
BACK TO LAWYER CENTRAL LEGAL NEWS CENTER
BYETTA PATIENTS REPORT KIDNEY PROBLEMS, LABEL REVISED
November 3, 2009
The labeling for Byetta, a drug used to treat type 2 diabetes, has been revised to include new safety information about possible kidney function problems, including kidney failure. Byetta was approved by the Food & Drug Administration (FDA) in 2005 to help type 2 diabetics better control blood sugar when other drugs were not adequate. The [...]Related Gadolinium Contrast Dye Stories:
- Cruise Ship Norovirus Study Points Finger at Dirty Public Bathrooms..
- Cambridge Silversmith Flatware Recalled for Choking Hazard..
- Some Answers on Chinese Drywall Expected This Week..
Additional Injury and Gadolinium Contrast Dye Resources:
Complete the Form Below and Talk to Experienced Lawyers
